Definium Therapeutics, Inc.
Company Information
Industry Medicinal Chemicals & Botanical Products
SIC Code 2833
Entity Type operating
SEC Category Emerging growth company
State of Incorporation British Columbia, Canada
Business Address ONE WORLD TRADE CENTER, NEW YORK, NY, 10007
Mailing Address ONE WORLD TRADE CENTER, NEW YORK, NY, 10007
Phone 212-220-6633
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2024
-$95.73M
Net Income
$241.45M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| 4 Insider stock transaction report | February 5, 2026 | View on SEC |
| 4 Insider stock transaction report | February 5, 2026 | View on SEC |
| 4 Insider stock transaction report | February 5, 2026 | View on SEC |
| 4 Insider stock transaction report | February 5, 2026 | View on SEC |
| 4 Insider stock transaction report | February 5, 2026 | View on SEC |
| 3 Initial insider ownership report | January 29, 2026 | View on SEC |
| 8-K Current report of material events | January 29, 2026 | View on SEC |
| 4 Insider stock transaction report | January 29, 2026 | View on SEC |
| 8-K Current report of material events | January 12, 2026 | View on SEC |
Insider Trading
STRONG SELL 3 insiders
3 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2833)
Charlie's Holdings, Inc.
CHUC Medicinal Chemicals & Botanical Products
Canopy Growth Corp
CGC Medicinal Chemicals & Botanical Products
biote Corp.
BTMD Medicinal Chemicals & Botanical Products
Bon Natural Life Ltd
BON Medicinal Chemicals & Botanical Products
Medikra Inc.
MDKR Medicinal Chemicals & Botanical Products
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.